NASDAQ: SOBRSobr Safe Inc Stock
$3.19-0.26 (-7.54%)
Updated Jun 13, 2025
SOBR Price
$3.19
Fair Value Price
N/A
Market Cap
$4.84M
52 Week Low
$0.24
52 Week High
$26.39
P/E
-0.02x
P/B
0.42x
P/S
2.46x
PEG
N/A
Dividend Yield
N/A
Revenue
$251.36k
Earnings
-$7.98M
Gross Margin
18.7%
Operating Margin
-3,084.57%
Profit Margin
-3,367.5%
Debt to Equity
0.1
Operating Cash Flow
-$7M
Beta
-7.48
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
SOBR Overview
SOBR Safe, Inc. develops a non-invasive alcohol detection and identity verification systems. It engages in the development of SOBRcheck, a stationary identification and alcohol monitoring product; SOBRsure, a transdermal, alcohol-detecting wearable band; and SOBRSafe software platform for non-invasive alcohol detection and identity verification. The company was formerly known as TransBiotec, Inc. and changed its name to SOBR Safe, Inc. in March 2020. The company was founded in 2004 and is based in Greenwood Village, Colorado.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine SOBR's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
F
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Scientific & Technical Instrument
Industry Rating
B
SOBR
Ranked#19 of 22
Ranked#19 of 22
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $89.37 | B | |
| $35.50 | B | |
| $158.19 | B |
Be the first to know about important SOBR news, forecast changes, insider trades & much more!
SOBR News
Overview
Due Diligence Score
–
Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SOBR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SOBR is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SOBR is good value based on its book value relative to its share price (0.42x), compared to the US Scientific & Technical Instruments industry average (3.24x)
P/B vs Industry Valuation
SOBR is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more SOBR due diligence checks available for Premium users.
Valuation
SOBR fair value
Fair Value of SOBR stock based on Discounted Cash Flow (DCF)
Price
$3.19
Fair Value
$2.46
Overvalued by
29.60%
SOBR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
SOBR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.02x
Industry
-0.59x
Market
31.36x
SOBR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.42x
Industry
3.24x
SOBR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SOBR's financial health
Profit margin
Revenue
$86.6k
Net Income
-$1.9M
Profit Margin
-2,228%
SOBR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SOBR's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$12.7M
Liabilities
$1.1M
Debt to equity
0.1
SOBR's short-term assets ($10.51M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SOBR's short-term assets ($10.51M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SOBR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.7M
Investing
$0.0
Financing
$3.4M
SOBR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
SOBR vs Scientific & Technical Instrument Stocks
Sobr Safe Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.